Genetic Variation in IL28B and Treatment-induced Clearance of Hepatitis C Virus in HIV-Positive Patients With Acute and Chronic Hepatitis C
Open Access
- 21 January 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 203 (5), 595-601
- https://doi.org/10.1093/infdis/jiq098
Abstract
Recently, a IL28B (rs 12979860) gene polymorphism was identified as a predictor for response to hepatits C virus–specific treatment in human immunodeficiency virus (HIV)–uninfected and –infected patients with chronic hepatitis C. In an analysis of HIV-infected patients with acute hepatitis C, we found that the IL28B genotype was associated with serum levels of hepatitis C virus RNA, g-GT, and CD4 cell count. In contrast to HIV-infected patients with chronic hepatitis C, the IL28B genotype was not significantly associated with treatment response rates in patients with acute hepatitis C. Thus, effects of the IL28B single-nucleotide polymorphism may differ in HIV-infected patients with chronic and acute hepatitis C.Keywords
This publication has 15 references indexed in Scilit:
- Replicated Association Between an IL28B Gene Variant and a Sustained Response to Pegylated Interferon and RibavirinGastroenterology, 2010
- Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patientsAIDS, 2010
- Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis CNature Genetics, 2009
- IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapyNature Genetics, 2009
- Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearanceNature, 2009
- Interferon signaling and treatment outcome in chronic hepatitis CProceedings of the National Academy of Sciences of the United States of America, 2008
- European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV‐infected adultsHIV Medicine, 2008
- Interferons α and λ Inhibit Hepatitis C Virus Replication With Distinct Signal Transduction and Gene Regulation KineticsGastroenterology, 2006
- IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complexNature Immunology, 2002
- Treatment of Acute Hepatitis C with Interferon Alfa-2bNew England Journal of Medicine, 2001